Aethlon Medical Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aethlon Medical, Inc. on March 17, 2026, covering events as of March 16, 2026. The company is incorporated in Nevada and its common stock trades on The Nasdaq Capital Market under the symbol AEMD.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a capital structure update.
Material Changes
- Warrant Exercises: The company reported recent exercises of certain pre-funded warrants.
- Share Count Update: As of the close of business on March 16, 2026, the company has 1,569,110 shares of common stock outstanding.
- Warrant Status: All previously outstanding pre-funded warrants have been fully exercised.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies beyond the completion of the warrant exercises.
Investor Verification Checklist
- Verify the updated share count of 1,569,110 in subsequent filings or market data.
- Confirm the full exercise of all pre-funded warrants to assess remaining dilution risks.
- Review the company's cash position post-exercise to understand the capital raised from these transactions.